Search research articles
Contact Us
Filters
Showing results (21-30 of 66) with videos related to
Page
of 7
Sort By:
Investigational New Drugs
|
January 1, 1997
A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma
M L Keohan, M R Grever, S P Balcerzak, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|
September 1, 1987
Vietnam veterans and soft tissue sarcoma
J D Constable, R Timperi, R Clapp, et al.
Human Gene Therapy
|
September 1, 1994
Human MDR gene transfer in patients with advanced cancer
C Hesdorffer, K Antman, A Bank, et al.
Clinical Genetics
|
March 25, 2000
An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2
R Moslehi, D Russo, C Phelan, et al.
Cancer Treatment Reports
|
July 1, 1986
Pharmacokinetics and immediate effects of high-dose carmustine in man
W D Henner, W P Peters, J P Eder, et al.
British Journal of Haematology
|
April 1, 1989
Enhancement of superoxide anion release by granulocytes harvested from patients receiving granulocyte-macrophage colony-stimulating factor
R Sullivan, J P Fredette, M Socinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1988
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985
K Antman, R Shemin, L Ryan, et al.
Blood
|
August 1, 1988
Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo
M A Socinski, S A Cannistra, R Sullivan, et al.
Journal of Hematotherapy
|
January 1, 1993
High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience
L J Ayash, A Elias, C Wheeler, et al.
Cancer
|
April 7, 1998
A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma
K Antman, J Crowley, S P Balcerzak, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 66) with videos related to
Sort By:
Page
of 7
Investigational New Drugs
|
January 1, 1997
A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma
M L Keohan, M R Grever, S P Balcerzak, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|
September 1, 1987
Vietnam veterans and soft tissue sarcoma
J D Constable, R Timperi, R Clapp, et al.
Human Gene Therapy
|
September 1, 1994
Human MDR gene transfer in patients with advanced cancer
C Hesdorffer, K Antman, A Bank, et al.
Clinical Genetics
|
March 25, 2000
An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2
R Moslehi, D Russo, C Phelan, et al.
Cancer Treatment Reports
|
July 1, 1986
Pharmacokinetics and immediate effects of high-dose carmustine in man
W D Henner, W P Peters, J P Eder, et al.
British Journal of Haematology
|
April 1, 1989
Enhancement of superoxide anion release by granulocytes harvested from patients receiving granulocyte-macrophage colony-stimulating factor
R Sullivan, J P Fredette, M Socinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1988
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985
K Antman, R Shemin, L Ryan, et al.
Blood
|
August 1, 1988
Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo
M A Socinski, S A Cannistra, R Sullivan, et al.
Journal of Hematotherapy
|
January 1, 1993
High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience
L J Ayash, A Elias, C Wheeler, et al.
Cancer
|
April 7, 1998
A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma
K Antman, J Crowley, S P Balcerzak, et al.
Page
of 7